Skip to content

Cardiovascular autonomic function and metabolomic profile in chronic obstructive pulmonary disease

Cardiovascular autonomic function and metabolomic profile in chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20220519004
Enrollment
88
Registered
2022-05-19
Start date
2022-05-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular autonomic function in chronic obstructive pulmonary disease (COPD) patients with all stages COPD, cardiovascular autonomic function

Interventions

COPD patients with autonomic dysfunction based on reference values in Thais.,COPD patients without autonomic dysfunction based on reference values in Thais.,Sex- and age- match control subjects
Screening,Screening,Screening
COPD with autonomic dysfunction,COPD without autonomic dysfunction,Non-COPD

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: COPD patients, all severity (mild, moderate, severe and very severe), as defined by the Global Initiative for Obstructive Lung Disease (GOLD) guidelines (2) with forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio < 0.7 will be recruited if they meet the following criteria: 1) Age between 40-80 years old; 2) Stable conditions, i.e. no acute exacerbation, change in pharmacological therapy, or hospital admission in the past 1 month; 3) Good ability to communicate and follow instructions.

Exclusion criteria

Exclusion criteria: Subjects of either group will be excluded from this study if they meet the following criteria: 1) History of diabetes mellitus, cardiac arrhythmias, lung cancer, or mental disorder; 2) Alcoholism and/or current smoker; 3) Musculoskeletal or neurological abnormalities, such as stroke, upper limb or lower limb injuries; 4) Acute conditions, such as fever, uncontrolled hypertension.

Design outcomes

Primary

MeasureTime frame
Heart rate variability 5 minutes Time-domain parameters: meanNN, SDNN, SDSD, NN50, pNN50, RMSSD,Heart rate variability 5 minutes Frequency-domain parameters: Total power, VLF, or the very low frequency component, LF, or the low frequency component, HF, or the high frequency component, LFnu, HFnu, LF/HF ratio,Blood pressure variability 5 minutes Time-domain parameters: meanBP, SD, SDSD, CV,Blood pressure variability 5 minutes Frequency-domain parameters: Total power, VLF, or the very low frequency component, LF, or the low frequency component, HF, or the high frequency component, LFnu, HFnu,Baroreflex sensitivity 5 minutes Sequence method,Ewing test 5 - 10 minutes for each test Heart rate response to standing, Blood pressure response to standing, Heart rate response to deep breathing, Heart rate response to Valsalva maneuver, Blood pressure response to handgrip exercise,Arterial stiffness Baseline measurement Ankle brachial index,Thai Innate body elements Baseline measurement Earth element, Water element, Wind element, Fire elements

Secondary

MeasureTime frame
Metabolomic profile After the end of autonomic function tests Metabolomic analysis

Countries

Thailand

Contacts

Public ContactAssociate Professor Dr. Wattana Watanapa

Department of Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University

wattanaw@gmail.com0814875265

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026